Tregalizumab
Product Specifications
CAS Number
1207446-68-1
Target
Immunology/Inflammation related
Related Pathways
Immunology/Inflammation
Purity
0.99
Bioactivity
Tregalizumab (BT-061) is a humanised monoclonal antibody targeting CD4, capable of binding unique epitopes on CD4 and selectively inducing regulatory T cell (Treg) activation. It holds potential applications in immunology and inflammation.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
583743-01 20 µg
B-cell Lymphoma/Leukemia 11B, Recombinant, Human, aa387-823, His-Tag, Myc-Tag
Sign In for Pricing
View Details 583743-02 100 µg
B-cell Lymphoma/Leukemia 11B, Recombinant, Human, aa387-823, His-Tag, Myc-Tag
Sign In for Pricing
View Details 